Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1991-04-30
1992-11-17
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119, A61K 31557
Patent
active
051644150
ABSTRACT:
A method of treatment of pancreatic disease which comprises administering, to a subject in need of such treatment, a 15-keto-prostaglandin compound in an amount effective in treatment of pancreatic disease.
REFERENCES:
patent: 5001154 (1991-03-01), Ueno
Avery's Drug Treatment, 3rd Edition pp. 1051-1053 (1987).
Experientia, vol. 45, No. 4, Apr. 15, 1989, pp. 352-355.
Prostaglandins, vol. 21, No. 5, May 1981, pp. 759-768.
Henley III Raymond J.
K.K. Ueno Seiyaku Oyo Kenkyujo
Waddell Frederick E.
LandOfFree
Treatment of pancreatic disease with 15-keto-prostaglandin compo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of pancreatic disease with 15-keto-prostaglandin compo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of pancreatic disease with 15-keto-prostaglandin compo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1172444